Diseases, Conditions, Syndromes

A scientist's perspective on the COVID-19 pandemic

Since the first case of coronavirus (COVID-19) was identified in December 2019, the respiratory virus has swept across the globe. Cases have been confirmed on every continent but Antarctica, prompting the World Health Organization ...

Medical research

Inactive pill ingredients could raise the dose of your medication

The average medication contains a mix of eight "inactive" ingredients added to pills to make them taste better, last longer, and stabilize the active ingredients within. Some of those additives are now getting a closer look ...

Medical research

New platform for cancer diagnostics and drug testing

Parts of tumor tissue, which is normally discarded in cancer surgery, bear information about the disease. So far, as studies at the University of Gothenburg show, this has been unexploited. This research forms the basis for ...

Diseases, Conditions, Syndromes

New compounds thwart multiple viruses, including coronavirus

According to a February 13 report from the World Health Organization, the Wuhan coronavirus has stricken more than 46,000 people and has caused over 1,300 deaths since the first cases in Wuhan, China, in December 2019. Now, ...

Alzheimer's disease & dementia

Drugs fail to slow decline in inherited Alzheimer's disease

Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because they inherited rare gene flaws.

Medications

Evolution of approval, regulation processes for drugs explored

(HealthDay)—The U.S. approval and regulation processes for pharmaceutical agents have evolved during the last four decades, according to a study published in the Jan. 14 issue of the Journal of the American Medical Association.

page 25 from 40